Phil Grayeski

Phil Grayeski is a prominent figure in the biotech investment and entrepreneurship space. He currently serves as a Partner at KdT Ventures, where he invests in early-stage biotech companies across various sectors including human health, climate technologies, and consumer bio.12

Professional Experience

Grayeski's career spans both investment and entrepreneurship:

Investment:

• Partner at KdT Ventures (October 2021 - Present)
• Previously held positions of Principal and Venture Associate at KdT Ventures

Entrepreneurship:

• Co-Founder of Torque Bio (June 2018 - Present)
• Previously involved in spinning out two therapeutics companies, StrideBio and Ribometrix, from UNC-Chapel Hill

Board Positions

Grayeski serves on the board of several biotech companies, including:

• Cyberdontics (February 2022 - Present)
• Andes (May 2020 - Present)
• Vecprobio, Inc. (August 2022 - Present)

He has also previously held board positions at Transcera Inc. and Dimension Inx.1

Education

Grayeski has a strong academic background:

• Ph.D. in Genetics from the University of North Carolina at Chapel Hill (2017 - 2021)
• M.Phil in Bioscience Enterprise from the University of Cambridge (2014 - 2015)
• B.S. in Genetics and Chemistry from the University of Georgia (2010 - 2014)

He is also an MD-PhD trainee at UNC-Chapel Hill's MSTP program, currently on leave from the MD training.2

Achievements

• Named a 2013 Barry M. Goldwater Scholar while at the University of Georgia3
• Recipient of the CR Lowe Carpe Diem - Life Science Young Entrepreneur of the Year award
• NHLBI F30 Fellowship recipient1

Grayeski is known for his focus on finding new companies in overscienced yet underfunded ecosystems outside traditional biotech hubs. His approach at KdT Ventures emphasizes being the "kindest" in the space, leveraging his operator background to provide valuable support to the companies they invest in.2